Categories
Nevin Manimala Statistics

Isolated Kratom Use Disorder Treated with Extended-Release Buprenorphine Taper

J Addict Med. 2024 May 22. doi: 10.1097/ADM.0000000000001328. Online ahead of print.

ABSTRACT

This case report highlights a 36-year-old male without history of psychiatric disease, chronic pain, or substance use disorder who developed severe substance use disorder per Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria to kratom. He was successfully treated with sublingual buprenorphine after a 3-year period of intermittent withdrawal management and trials of oral and extended-release injectable naltrexone. After a period of abstinence from kratom, he was tapered from buprenorphine using 2 monthly injections of 100 mg extended-release buprenorphine. His case underscores some of the current uncertainties around kratom use disorder diagnosis and treatment.

PMID:38776432 | DOI:10.1097/ADM.0000000000001328

By Nevin Manimala

Portfolio Website for Nevin Manimala